SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wyeth trades jubilantly on getting nod for scheme of amalgamation

25 Nov 2013 Evaluate

Wyeth is currently trading at Rs. 893.00, up by 78.85 points or 9.68% from its previous closing of Rs. 814.15 on the BSE.

The scrip opened at Rs. 976.95 and has touched a high and low of Rs. 976.95 and Rs. 875.00 respectively. So far 181348 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 989.00 on 30-Nov-2012 and a 52 week low of Rs. 553.05 on 06-Sep-2013.

Last one week high and low of the scrip stood at Rs. 976.95 and Rs. 613.50 respectively. The current market cap of the company is Rs. 2006.18 crore.

The promoters holding in the company stood at 51.12% while Institutions and Non-Institutions held 18.82% and 30.06% respectively. Wyeth’s board of directors at its meeting held on November 23, 2013 has approved the Scheme of Amalgamation of Wyeth with Pfizer under the provisions of Sections 391 to 394 and other applicable provisions of the Companies Act, 1956.

Wyeth is the Indian subsidiary of US-based Pharma Company Wyeth, a global leader in pharmaceutical, consumer healthcare and animal health products. It was established in 1947 as a company under the name Lederle Laboratories (India). In 1962, the name was changed to Cyanamid India.

Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×